Colin is now Chairman of NISW following the departure of
Susan Lambert. He also remains the Chairman of the
Strategy Board of the Health & Wellbeing Innovation Centre in
Truro and Vice Chairman of Cornwall Mobility Centre
Ltd. He is a director of NHS Innovations South West Ltd
and a Visiting Professor and Consultant to the Peninsula Medical
School. A recognised expert in the design of medical
instruments he chaired the Design Council's awards panel for
medical equipment for many years.
Colin acts regularly as an expert witness in the field of medical
instrumentation and IP protection. He has worked as an
adviser on medical engineering to UK, Canadian, Italian, Swedish
and Australian Research Councils, the EU, UN and WHO, as well as
acting as Expert Européen to INSERM for a number of
years. He has also acted as consultant to many firms
working in medical technology. He has served on a number of
governmental committees for both the Cabinet Office and Department
of Health as well as the Science & Engineering Research
Council. He chaired the FDP2 Programme Management
Committee for the National Institute for Health Research's i4i
(Invention for Innovation) Programme and is now Co Chairman of its
Early Stage Programme
As Chief Executive Officer, Mike brings a wide experience in the
Healthcare and wellbeing market with the capability of facilitating
the development of solutions that meet the needs of the ultimate
user. With an original lifescience research background in the
NHS followed by a commercial business career against the backdrop
of working at the UKs leading technology organisation, QinetiQ,
Mike can bring a rounded perspective to an opportunity.
Particular areas of expertise include:
• account management / CRM
• business development
• value proposition building
• venture capital backed technology exploitation deals
• technology transfer licensing and exploitation of IP
• medical applications of a broad range of high technology
• research (market and science)
• direct selling
• general management in a distributed organisation
• online brand management / presence
Malcolm Cassells is a qualified accountant with over twenty five
years board level experience within the NHS. He has a particular
interest in innovation and improving practice, and oversaw the
establishment of the South West Innovation Hub, which later became
NHS Innovations South West Ltd.
He established the first NHS owned company in England, Odstock
Medical Ltd (OML), which is successfully exploiting patented
intellectual property developed within the NHS and he remains one
of its board members.
He is married with three grown up children and lives in South
Sue has recently joined the board of NISW and brings broad
experience in IP commercialisation from the perspective of large
multi-nationals, SMEs and leading universities. She is currently
head of Research Commercialisation at the University of Bristol,
responsible for a team which reviews and protects intellectual
property generated by Bristol academics, and then identifies
the most appropriate route to bring it to market.
Previously Sue was Head of Life-sciences at the University of
Southampton where she was responsible for a team handling
contracts, licensing and spin-out creation on behalf of the Faculty
of Medicine, Health and Life-sciences. She has also operated
as an independent consultant, undertaking projects in life-sciences
market research and licensing for companies and publicly funded
Sue has also been a Non-Executive director of 7 life-science
SMEs and helped to raise over £30m and listing on the AIM.
Before joining the University, she spent 20 years with Astrazeneca,
where she held a wide range of international commercial positions
including General Management, marketing and global business
development and was responsible for multi-million dollar deals, the
sale of non-strategic companies and the creation of new companies
in line with developing strategic priorities. Sue graduated
from the London Business School and Wharton MBA programme with
Philip Sharpe is a Non-Executive Director of NHS Innovations
Philip is Portfolio and Strategy Support Director at QinetiQ, a
leading defence research company based in UK, US and Australia.
Formerly a research leader in QinetiQ's predecessor companies,
Philip has worked on technology based venturing since 1999 and been
intimately involved in all stages of technology commercialisation.
Mentoring early stage propositions and businesses has been at the
heart of Philip's activities for over a decade.
Philip is a non-exec director at the University of Southampton
Science Park, where he provides strategy support to the CEO and
start-up mentoring; he is also QinetiQ's non-exec director on the
board of Sciemus Ltd a London based insurance services company.
Philip trained as a physicist and has an MSc in
As a graduate of the first Trust Innovation Leader Programme in
2007 Rachel is delighted to join the Board of NISW as a
non-executive director. Committed to the aims and values of
the NHS, Rachel brings experience of enabling innovation in acute
and mental health settings.
With a life sciences background, Rachel worked in health
research and research management for many years before undertaking
the TIL programme which paved the way for a number of roles
supporting NHS innovation and enterprise. She has experience
of commercialising intellectual property, working with NHS staff to
develop their ideas from concept through to licensing, as well as
commercialising NHS knowledge and expertise.
Through hands on experience Rachel recognised that innovation
must be deliberate, planned and aligned with strategic priorities
if it is to deliver value to an organisation. This motivated
her move into the field of organisational development. In her
current role as Director of Organisational Development in Avon and
Wiltshire Mental Health Partnership NHS Trust, Rachel's
responsibilities include staff engagement and development, enabling
Trust strategy and cultural transformation.